|

Pelareorep Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since May 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Oncolytics Biotech1

Indications

  • Ras-mutated Metastatic Colorectal Cancer1
  • MSS Metastatic Colorectal Cancer1
  • MCRC1
  • Cancer1

Homewood, Alabama1 trial

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Central Alabama Research

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.